Atara Biotherapeutics (ATRA) Interest Expenses (2022 - 2026)
Atara Biotherapeutics' Interest Expenses came in at $191,000 for Q2 2026, down 80.3% from $972,000 a year earlier and down 77.0% from the prior quarter.
Atara Biotherapeutics (ATRA) Interest Expenses (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Atara Biotherapeutics reported Interest Expenses of $2.82 million, down 32.6% year-over-year; for FY2025, it came in at $3.79 million, down 17.8% from FY2024.
- Interest Expenses carries a three-year compound annual growth rate of 116.6% (FY2022 to FY2025).
- Going back by year, Interest Expenses was $4.62 million in FY2024 (-12.7%), $5.29 million in FY2023 and $373,000 in FY2022.
- The Q2 2026 figure represents the lowest quarterly Interest Expenses since Q4 2022.
- Year-over-year, Interest Expenses has declined for ten consecutive quarters, with an average decline of 24.7% over the last eight quarters.
- The fastest year-over-year change in Interest Expenses over five years came in Q2 2023 (growth of 968.2%), and the weakest in Q2 2026 (a decline of 80.3%).
- Business Quant data shows ATRA's Interest Expenses at $830,000 (Q1 2026), $894,000 (Q4 2025) and $909,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | - |
| 10 | Atara Biotherapeutics | 141.76 Mn | 131.86 Mn | 439,000.00 | 191,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 191,000.00 |
| Mar 31, 2026 | 830,000.00 |
| Dec 31, 2025 | 894,000.00 |
| Sep 30, 2025 | 909,000.00 |
| Jun 30, 2025 | 972,000.00 |
| Mar 31, 2025 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 117,000.00 |
| Sep 30, 2022 | 123,000.00 |
| Jun 30, 2022 | 129,000.00 |
| Mar 31, 2022 | 4,000.00 |
Atara Biotherapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=ATRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();